This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cleophas, T. J.M. Articles by van 't Laar, A. Search for Related Content PubMed PubMed Citation Articles by Cleophas, T. J.M. Articles by van 't Laar, A. Social Bookmarking                         What's this?

Alpha and Beta-Blockade and Beta-Stimulation in Raynaud's Syndrome: A Double-Blind, Placebo Controlled, Single Dose Study

Division of General Internal Medicine, Department of Medicine, University of Nijmegen, Nijmegen, The Netherlands

Jan F.M. Fennis

Division of General Internal Medicine, Department of Medicine, University of Nijmegen, Nijmegen, The Netherlands

Albert van 't Laar

Division of General Internal Medicine, Department of Medicine, University of Nijmegen, Nijmegen, The Netherlands

We examined in a double blind fashion and placebo controlled the effects of some alpha and beta adrenergic receptor agonists and antagonists on the recov ery of finger skin temperature 12 min after finger cooling (5 min waterbath for both hands) in twelve patients with Raynaud's syndrome. A favourable effect was established on phenoxybenzamine 20 mg as compared to placebo. A signifi cant but rather small effect on orciprenaline 10 mg. The beta-agonists pre nalterol (10 mg) and terbutaline (5 mg) did not influence the recovery of finger skin temperature. The beneficial effect of phenoxybenzamine 20 mg was not influenced by the addition of beta-agonists (prenalterol 10 mg or terbutaline 5 mg) or a beta-blocker (propranolol 40 mg).

The beta-agonists terbutaline and orciprenaline caused a fall in diastolic pressure and an increase in heart rate. These effects presumably were con nected with one collaps and three near-collapses. On alpha- and beta-blocker (phenoxybenzamine and propranolol) a decrease in systolic pressure appeared, whereas diastolic pressure did not significantly differ from the placebo value. While physical exercise is considered to exacerbate the hypotensive effect of alpha-blockers, a fall in blood pressure during physical exercise could not be established in our experiments after the addition of propranolol to the alpha- blocker phenoxybenzamine. Our results suggest that an alpha-blocker is a good choice in Raynaud's syndrome, whereas the addition of a beta-blocker may have some advantages.

Angiology, Vol. 36, No. 4, 219-225 (1985)
DOI: 10.1177/000331978503600404


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. J. M. Cleophas Criticism of Cardiovascular Studies with Negative Results Due to a Negative Correlation Angiology, February 1, 1996; 47(2): 139 - 147. [Abstract] [PDF]

				T. J. M. Cleophas and M. G. Niemeyer Raynaud's Syndrome, an Enigma After 130 Years Angiology, March 1, 1993; 44(3): 196 - 209. [Abstract] [PDF]

				D. M. Hood, M. S. Amoss, and D. A. Grosenbaugh Equine Laminitis: A Potential Model of Raynaud's Phenomenon Angiology, April 1, 1990; 41(4): 270 - 277. [Abstract] [PDF]

				T. J. M. Cleophas and F. H. W. Kauw Pressor Responses from Noncardioselective Beta-Blockers Angiology, July 1, 1988; 39(7): 587 - 596. [Abstract] [PDF]